Mindful Innovation Bringing Hope to Patients

Developing new treatments to improve the lives of patients and families affected by epilepsy and neuropsychiatric disorders.

Our Pledge to Patients

Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new mechanism of action with safe and convenient dosing, for adult and pediatric patient populations in acute and chronic care settings.

Our Science & Pipeline

Postpartum Depression

Striving to Support Strong Mother-Baby Bonds

Developing therapies with the potential to address postpartum depression more quickly and in an outpatient setting.

Learn More

Orphan Epilepsies

Aspiring to Give Children Seizure-Free Days

Ganaxolone offers the potential to safely decrease seizure frequency in children with refractory epilepsy.

Learn More

Why We Work

To make a difference in the lives of patients and their families.

  • Violet

    “She spends time at the park and beach, works hard in school, loves playing with her little brother, and making new friends.”

  • Artwork by G

    “Meet our special little guy who enjoys creating beautiful pieces of art with his mommy to help raise awareness for CDKL5.”

  • Sloan

    “Sloan surprises us with new skills every day and is the sweetest, funniest, spunkiest little girl our family could have been blessed to have.”

  • Artwork by Ava

    This artwork was made by young Ava.

  • Kiera

    “She is a vibrant and intelligent young lady who has a wonderful sense of humor, love for music, dancing, and the moon and stars.”

  • Amanda

    “We call our daughter Amazing Amanda, and quite simply… she IS. Her strength and tenacity wows me; she is my hero!”


Follow Us on Twitter

“Women who experience #PPD think they're horrible moms. They think if they tell anybody how they feel, they'll be judged and their baby will be taken away. That's the underlying thought. And it often holds women back from asking for help.” Adrienne Griffen, @PostpartumVA

“Some women don’t have #PPD symptoms for a long time, or they have symptoms and they hide it from their partner/family. But either way, every woman who goes through this feels like she is all alone.” Adrienne Griffen, @PostpartumVA

For families of CDKL5 patients, support is critical. One mother: “We now had a support system of other parents going through the same things. Somebody who knows my feelings, that level of desperation, and really understands. They know I don’t want sympathy, but understanding.”

Sign Up For Updates

Receive periodic updates on program progress, clinical trials, and other timely information.